Personally I've always felt that ADAPT was the main driver for AHZ.
I've ignored the vaccine biz as the chances of success are slim.
On ADAPT alone I see AHZ moving towards $1 within 4 years.
it is the gold standard soft tissue patch, it has multiple potential applications within the human body.
Yes competition could appear but I haven't seen any yet. They raised capital to build their salesforce and capitalise on this opportunity. The numbers should start to reflect this in the next Qrtly.
- Forums
- ASX - By Stock
- AVR
- Article on news.com.au
Article on news.com.au, page-55
-
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$14.22 |
Change
-0.030(0.21%) |
Mkt cap ! $295.9M |
Open | High | Low | Value | Volume |
$14.20 | $14.76 | $13.70 | $314.4K | 22.19K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1116 | $14.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.22 | 88 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1116 | 14.100 |
2 | 700 | 14.050 |
1 | 113 | 14.000 |
1 | 1000 | 13.900 |
1 | 167 | 13.700 |
Price($) | Vol. | No. |
---|---|---|
14.220 | 88 | 1 |
14.260 | 124 | 2 |
14.300 | 1000 | 1 |
15.000 | 421 | 1 |
15.150 | 149 | 1 |
Last trade - 14.15pm 12/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |